Over 200 years of combined innovation and clinical use
Pratap Khanwilkar, PhD, MBA, CEO
Veteran of 34 medtech startups and 5 exits (1 full MagLev implantable LVAD). Helped 4 VAD/TAHs advance from concept to clinic. Demonstrated capital efficiency: as Founder/CEO, took a full MagLev implantable LVAD from concept to First-In-Human (FIH) on $36 million in total capital. Heart failure patient.
James Antaki, PhD, FNAI, CTO
Inventor of Hemoglide and PediaFlow; Endowed Professor of Heart- Assist Technology at Cornell with four decades of blood pump innovation. Along with Pratap, helped create the full maglev durable VAD/TAH field since the early '90s, exemplified with the Levacor VAD.
Bartley P. Griffith, MD, CMO
Renowned cardiac surgery pioneer at the University of Maryland (formerly at University of Pittsburgh/UPMC); clinical leader and innovator in artificial organs (heart, lung) and xenotransplantation (world's first transplant of pig heart in humans).
Harvey Borovetz, PhD, Founder, Advisor
ECMO pioneer who established the world’s highest-volume MCS clinical program at UPMC (University of Pittsburgh Medical Center).
Salim Olia, PhD, VP of Clinical Affairs
Clinical Bioengineer with decades+ experience in development, pre-clinical testing and clinical deployment of MCS technologies in more than 2,000 patients.